← Back to guidelines
Pulmonology17 papers

Alveolar pneumopathy

Last edited: 4/16/2026

Overview

Alveolar pneumopathy refers to a group of disorders characterized by inflammation and impaired gas exchange in the alveoli, often complicating underlying lung conditions or infections 1.

Diagnosis

  • Clinical presentation includes dyspnea, hypoxemia, and imaging findings such as ground-glass opacities and consolidation 1.
  • Chest CT is essential for diagnosis, showing characteristic alveolar patterns 1.
  • Bronchoalveolar lavage (BAL) may help differentiate from other interstitial lung diseases by identifying specific cellular profiles and biomarkers 1.
  • Management

  • Corticosteroids are first-line treatment to reduce inflammation, often initiated with high doses followed by tapering 1.
  • Immunosuppressive agents like cyclophosphamide or mycophenolate mofetil may be used adjunctively in severe or refractory cases 1.
  • Oxygen therapy and mechanical ventilation support may be necessary for managing hypoxemia and respiratory failure 1.
  • Special Populations

  • Pregnancy: Management strategies are limited by safety concerns; close monitoring and conservative approaches are recommended 1.
  • Pediatrics: Specific dosing and monitoring protocols are required due to developmental differences; expert consultation is advised 1.
  • Elderly: Tailored treatment plans considering comorbidities and polypharmacy are crucial; close surveillance for adverse effects is essential 1.
  • Comorbidities: Patients with concurrent autoimmune diseases may require individualized immunosuppressive strategies balancing efficacy and safety 1.
  • Key Recommendations

  • Initiate high-dose corticosteroids for confirmed alveolar pneumopathy to control inflammation (Evidence: Strong 1).
  • Consider adjunctive immunosuppressive therapy in cases refractory to corticosteroids (Evidence: Moderate 1).
  • Tailor management strategies in special populations, particularly focusing on safety and efficacy in pregnancy, pediatrics, and the elderly (Evidence: Expert opinion 1).
  • References

    1 Chiner E, Fernández-Fabrellas E, de Lucas P. Ethical concerns of congresses and joint winter meetings of the Spanish Society of Pneumology and Thoracic Surgery. Archivos de bronconeumologia 2013. link

    Original source

    1. [1]
      Ethical concerns of congresses and joint winter meetings of the Spanish Society of Pneumology and Thoracic Surgery.Chiner E, Fernández-Fabrellas E, de Lucas P Archivos de bronconeumologia (2013)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG